Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators

被引:31
作者
Qian, Yimin [1 ]
Bolin, David [1 ]
Conde-Knape, Karin [2 ]
Gillespie, Paul [1 ]
Hayden, Stuart [1 ]
Huang, Kuo-Sen [3 ]
Olivier, Andree R. [2 ]
Sato, Tsutomu [1 ]
Xiang, Qing [3 ]
Yun, Weiya [1 ]
Zhang, Xiaolei [3 ]
机构
[1] Hoffmann La Roche Inc, Discovery Chem, Small Mol Res, Pharmaceut Res & Early Drug Dev, Nutley, NJ 07110 USA
[2] Hoffmann La Roche Inc, Metab & Vasc Dis, Pharmaceut Res & Early Drug Dev, Nutley, NJ 07110 USA
[3] Hoffmann La Roche Inc, Discovery Technol, Small Mol Res, Pharmaceut Res & Early Drug Dev, Nutley, NJ 07110 USA
关键词
Glycogen synthase; Enzyme activation; Type 2 diabetes (T2D); Metabolic stability; Indazolone; N-arylation and cyclization; DEPENDENT DIABETES-MELLITUS; COUPLING REACTIONS; ARYL HYDRAZIDES; INSULIN; BROMIDES;
D O I
10.1016/j.bmcl.2013.03.049
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Glycogen synthase (GS) catalyzes the transfer of glucose residues from UDP-glucose to a glycogen polymer chain, a critical step for glucose storage. Patients with type 2 diabetes normally exhibit low glycogen levels and decreased muscle glucose uptake is the major defect in whole body glucose disposal. Therefore, activating GS may provide a potential approach for the treatment of type 2 diabetes. In order to identify non-carboxylic acids GS activators, we designed and synthesized a series of 2-N-alkyl- and 2-N-aryl-indazolone derivatives and studied their activity in activating human GS. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2936 / 2940
页数:5
相关论文
共 22 条
[1]  
[Anonymous], 239 ACS NAT M SAN FR
[2]  
[Anonymous], [No title captured], Patent No. [8,039,495, 8039495]
[3]  
[Anonymous], UNPUB
[4]  
[Anonymous], [No title captured], Patent No. [0,112,147, 0112147]
[5]  
[Anonymous], [No title captured], Patent No. [067,266, 067266]
[6]   Structural basis for glucose-6-phosphate activation of glycogen synthase [J].
Baskaran, Sulochanadevi ;
Roach, Peter J. ;
DePaoli-Roach, Anna A. ;
Hurley, Thomas D. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (41) :17563-17568
[7]   Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes [J].
Cline, GW ;
Petersen, KF ;
Krssak, M ;
Shen, J ;
Hundal, RS ;
Trajanoski, Z ;
Inzucchi, S ;
Dresner, A ;
Rothman, DL ;
Shulman, GI .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (04) :240-246
[8]   ASSOCIATION BETWEEN POLYMORPHISM OF THE GLYCOGEN-SYNTHASE GENE AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS [J].
GROOP, LC ;
KANKURI, M ;
SCHALINJANTTI, C ;
EKSTRAND, A ;
NIKULAIJAS, P ;
WIDEN, E ;
KUISMANEN, E ;
ERIKSSON, J ;
FRANSSILAKALLUNKI, A ;
SALORANTA, C ;
KOSKIMIES, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (01) :10-14
[9]   Room-temperature palladium-catalyzed amination of aryl bromides and chlorides and extended scope of aromatic C-N bond formation with a commercial ligand [J].
Hartwig, JF ;
Kawatsura, M ;
Hauck, SI ;
Shaughnessy, KH ;
Alcazar-Roman, LM .
JOURNAL OF ORGANIC CHEMISTRY, 1999, 64 (15) :5575-5580
[10]   Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects - Biochemical and molecular mechanisms [J].
Henry, RR ;
Ciaraldi, TP ;
AbramsCarter, L ;
Mudaliar, S ;
Park, KS ;
Nikoulina, SE .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) :1231-1236